Gordon Ringold
9Patents
5h-index
10Co-inventors
60Inventor score
Filing activity: Apr 12, 1985 → Feb 25, 2025
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4656134A | Gene amplification in eukaryotic cells | Chemistry; Metallurgy | 141 | Expired |
| US5795779A | Human interferon-.beta. (IFN-.beta.) produced in Chinese hamster ovary (CHO) cells | Emerging Cross-Sectional Technologies | 77 | Expired |
| US4966843A | Expression of interferon genes in Chinese hamster ovary cells | Emerging Cross-Sectional Technologies | 50 | Expired |
| US5376567A | Expression of interferon genes in Chinese hamster ovary cells | Emerging Cross-Sectional Technologies | 43 | Expired |
| US4684623A | Use of tumor necrosis factor as a weight regulator | Emerging Cross-Sectional Technologies | 13 | Expired |
| US9783487B2 | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US10017459B2 | β-substituted β-amino acids and analogs as chemotherapeutic agents and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12427124B1 | Phenylalanine-based LAT1 inhibitors and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10246406B2 | Beta-substituted beta-amino acids and analogs as chemotherapeutic agents and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.